Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1934 1
1940 1
1945 1
1946 1
1947 1
1948 5
1949 2
1950 8
1951 10
1952 3
1953 1
1956 1
1957 3
1958 1
1959 2
1960 4
1961 7
1962 4
1963 6
1964 3
1965 7
1966 5
1967 1
1968 3
1969 2
1970 2
1971 1
1973 4
1974 1
1975 5
1976 2
1977 7
1978 7
1979 9
1980 9
1981 2
1982 7
1983 8
1984 4
1985 7
1986 10
1987 2
1988 5
1989 10
1990 8
1991 4
1992 7
1993 6
1994 14
1995 16
1996 16
1997 18
1998 23
1999 16
2000 10
2001 11
2002 17
2003 11
2004 19
2005 27
2006 16
2007 24
2008 22
2009 32
2010 22
2011 30
2012 29
2013 35
2014 41
2015 34
2016 36
2017 51
2018 32
2019 53
2020 48
2021 56
2022 48
2023 54
2024 59
2025 40

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,084 results

Results by year

Filters applied: . Clear all
Page 1
Landscape and Dynamics of Single Immune Cells in Hepatocellular Carcinoma.
Zhang Q, He Y, Luo N, Patel SJ, Han Y, Gao R, Modak M, Carotta S, Haslinger C, Kind D, Peet GW, Zhong G, Lu S, Zhu W, Mao Y, Xiao M, Bergmann M, Hu X, Kerkar SP, Vogt AB, Pflanz S, Liu K, Peng J, Ren X, Zhang Z. Zhang Q, et al. Among authors: vogt ab. Cell. 2019 Oct 31;179(4):829-845.e20. doi: 10.1016/j.cell.2019.10.003. Cell. 2019. PMID: 31675496 Free article.
Trial of Prasinezumab in Early-Stage Parkinson's Disease.
Pagano G, Taylor KI, Anzures-Cabrera J, Marchesi M, Simuni T, Marek K, Postuma RB, Pavese N, Stocchi F, Azulay JP, Mollenhauer B, López-Manzanares L, Russell DS, Boyd JT, Nicholas AP, Luquin MR, Hauser RA, Gasser T, Poewe W, Ricci B, Boulay A, Vogt A, Boess FG, Dukart J, D'Urso G, Finch R, Zanigni S, Monnet A, Pross N, Hahn A, Svoboda H, Britschgi M, Lipsmeier F, Volkova-Volkmar E, Lindemann M, Dziadek S, Holiga Š, Rukina D, Kustermann T, Kerchner GA, Fontoura P, Umbricht D, Doody R, Nikolcheva T, Bonni A; PASADENA Investigators; Prasinezumab Study Group. Pagano G, et al. Among authors: vogt a. N Engl J Med. 2022 Aug 4;387(5):421-432. doi: 10.1056/NEJMoa2202867. N Engl J Med. 2022. PMID: 35921451 Clinical Trial.
The Alopecia Areata Severity and Morbidity Index (ASAMI) Study: Results From a Global Expert Consensus Exercise on Determinants of Alopecia Areata Severity.
ASAMI Consensus Survey Study Group; Moussa A, Bennett M, Wall D, Meah N, York K, Bokhari L, Asfour L, Rees H, Abraham LS, Asz-Sigall D, Basmanav FB, Bergfeld W, Betz RC, Bhoyrul B, Blume-Peytavi U, Callender V, Chitreddy V, Combalia A, Cotsarelis G, Craiglow B, Dhurat R, Donovan J, Doroshkevich A, Eisman S, Farrant P, Ferrando J, Gadzhigoroeva A, Green J, Grimalt R, Harries M, Hordinsky M, Irvine A, Jolliffe V, Kaiumov S, King B, Lee J, Lee WS, Li J, Lortkipanidze N, McMichael A, Mesinkovska NA, Messenger A, Mirmirani P, Olsen E, Orlow SJ, Ovcharenko Y, Piraccini BM, Pirmez R, Rakowska A, Reygagne P, Rudnicka L, Corralo DS, Senna M, Shapiro J, Sharma P, Siliuk T, Starace M, Suchonwanit P, Takwale A, Tosti A, Vañó-Galván S, Visser WI, Vogt A, Wade M, Yip L, Zhou C, Sinclair R. ASAMI Consensus Survey Study Group, et al. Among authors: vogt a. JAMA Dermatol. 2024 Mar 1;160(3):341-350. doi: 10.1001/jamadermatol.2023.5869. JAMA Dermatol. 2024. PMID: 38324292 Free article.
Alopecia areata - Aktuelles Verständnis und Management.
Lintzeri DA, Constantinou A, Hillmann K, Ghoreschi K, Vogt A, Blume-Peytavi U. Lintzeri DA, et al. Among authors: vogt a. J Dtsch Dermatol Ges. 2022 Jan;20(1):59-93. doi: 10.1111/ddg.14689_g. J Dtsch Dermatol Ges. 2022. PMID: 35040563 German.
Cicatricial alopecia.
Kanti V, Röwert-Huber J, Vogt A, Blume-Peytavi U. Kanti V, et al. Among authors: vogt a. J Dtsch Dermatol Ges. 2018 Apr;16(4):435-461. doi: 10.1111/ddg.13498. J Dtsch Dermatol Ges. 2018. PMID: 29645394 Review.
A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data.
Pagano G, Boess FG, Taylor KI, Ricci B, Mollenhauer B, Poewe W, Boulay A, Anzures-Cabrera J, Vogt A, Marchesi M, Post A, Nikolcheva T, Kinney GG, Zago WM, Ness DK, Svoboda H, Britschgi M, Ostrowitzki S, Simuni T, Marek K, Koller M, Sevigny J, Doody R, Fontoura P, Umbricht D, Bonni A; PASADENA Investigators; Prasinezumab Study Group. Pagano G, et al. Among authors: vogt a. Front Neurol. 2021 Oct 1;12:705407. doi: 10.3389/fneur.2021.705407. eCollection 2021. Front Neurol. 2021. PMID: 34659081 Free PMC article.
LY6G6D is a selectively expressed colorectal cancer antigen that can be used for targeting a therapeutic T-cell response by a T-cell engager.
Corrales L, Hipp S, Martin K, Sabarth N, Tirapu I, Fuchs K, Thaler B, Walterskirchen C, Bauer K, Fabits M, Bergmann M, Binder C, Chetta PM, Vogt AB, Adam PJ. Corrales L, et al. Among authors: vogt ab. Front Immunol. 2022 Sep 8;13:1008764. doi: 10.3389/fimmu.2022.1008764. eCollection 2022. Front Immunol. 2022. PMID: 36159851 Free PMC article.
1,084 results